Jenkins Amends Catheter Precision Stake; Signals Ownership Change

Ticker: VTAK · Form: SC 13D/A · Filed: Jan 16, 2024 · CIK: 1716621

Catheter Precision, Inc. SC 13D/A Filing Summary
FieldDetail
CompanyCatheter Precision, Inc. (VTAK)
Form TypeSC 13D/A
Filed DateJan 16, 2024
Risk Levelmedium
Pages9
Reading Time11 min
Key Dollar Amounts$0.0001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: insider-ownership, amendment, corporate-governance

TL;DR

**Insider David A. Jenkins just updated his stake in Catheter Precision, Inc., signaling a change in his ownership.**

AI Summary

David A. Jenkins and his associated entities (DALIN CLASS TRUST, FATBOY CAPITAL, L.P., JENKINS FAMILY CHARITABLE INSTITUTE, LINDA JENKINS CHARITABLE REMAINDER UNITRUST, and SEACAP MANAGEMENT LLC) filed an amendment to their Schedule 13D on January 16, 2024, indicating a change in their beneficial ownership of Catheter Precision, Inc. common stock. This amendment, triggered by an event on January 10, 2024, updates their previous filing regarding their significant stake in the company. This matters to investors because it signals that a major insider, David A. Jenkins, is adjusting his position, which could reflect his updated view on the company's prospects or strategic direction.

Why It Matters

This filing indicates a change in the beneficial ownership of a significant insider, David A. Jenkins, which can influence investor sentiment and potentially signal future strategic moves for Catheter Precision, Inc.

Risk Assessment

Risk Level: medium — Changes in significant insider ownership can introduce uncertainty regarding the company's future direction or valuation.

Analyst Insight

Investors should monitor subsequent filings from David A. Jenkins and Catheter Precision, Inc. for further details on the nature of this ownership change and any potential implications for the company's strategy or stock performance.

Key Players & Entities

  • David A. Jenkins (person) — filing person and beneficial owner
  • Catheter Precision, Inc. (company) — the issuer of the securities
  • DALIN CLASS TRUST (company) — group member associated with Jenkins
  • FATBOY CAPITAL, L.P. (company) — group member associated with Jenkins
  • JENKINS FAMILY CHARITABLE INSTITUTE (company) — group member associated with Jenkins
  • LINDA JENKINS CHARITABLE REMAINDER UNITRUST (company) — group member associated with Jenkins
  • SEACAP MANAGEMENT LLC (company) — group member associated with Jenkins
  • $0.0001 (dollar_amount) — par value of common stock

Forward-Looking Statements

  • The change in beneficial ownership by David A. Jenkins could precede further strategic announcements or shifts in company governance for Catheter Precision, Inc. (Catheter Precision, Inc.) — medium confidence, target: Q1 2024

FAQ

Who filed this SC 13D/A amendment?

The SC 13D/A amendment was filed by David A. Jenkins, along with group members DALIN CLASS TRUST, FATBOY CAPITAL, L.P., JENKINS FAMILY CHARITABLE INSTITUTE, LINDA JENKINS CHARITABLE REMAINDER UNITRUST, and SEACAP MANAGEMENT LLC.

What is the subject company of this filing?

The subject company of this filing is Catheter Precision, Inc., with the CUSIP Number 74933X302 for its Common Stock, $0.0001 Par Value.

What was the date of the event that required this filing?

The date of the event which required the filing of this statement was January 10, 2024.

What is the par value of Catheter Precision, Inc.'s common stock?

The par value of Catheter Precision, Inc.'s common stock is $0.0001.

What is the business address of Catheter Precision, Inc.?

The business address of Catheter Precision, Inc. is 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708.

Filing Stats: 2,812 words · 11 min read · ~9 pages · Grade level 9.6 · Accepted 2024-01-16 08:15:49

Key Financial Figures

  • $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 Par Value (Title of Class of Securiti

Filing Documents

. Security and Issuer

Item 1 . Security and Issuer This Amendment No. 1 to Schedule 13D relates to the common stock, $0.0001 par value per share (the "Common Stock"), of Catheter Precision, Inc., a Delaware corporation (the "Company"). The original Schedule 13D was filed on March 29, 2023. (the "Initial Schedule 13D"). The Initial Schedule 13D is incorporated by reference herein. The principal executive office of the Company is located at: 1670 Highway 160 West Suite 205 Fort Mill, SC 29708

Identity and Background

Item 2. Identity and Background 1. (a) David Jenkins is a reporting person filing this statement. (b) c/o of Catheter Precision, Inc., 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708. (c) Executive Chairman of the Board and Chief Executive Officer of the Company, engaged in the design, manufacture and sale of new and innovative medical technologies focused in the field of cardiac electrophysiology, the business address of which is 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708. (d) None. (e) None. (f) United States. . CUSIP No. 74933X302 Page 9 of 13 2. Fatboy Capital, L.P. is a reporting person filing this statement. It is a Delaware limited partnership, and its principal business address is 9611 North US Hwy 1, Box 390, Sebastian FL 32958. Its principal business is to serve as a private investment holding company (d) None. (e) None. 3. The Jenkins Family Charitable Institute is a reporting person filing this statement. It is a private foundation, and its principal business address is 9611 North US Hwy 1, Box 390, Sebastian FL 32958. Its principal business is to serve as a family charitable entity. (d) None. (e) None. 4. The Linda Jenkins Charitable Remainder Unitrust is a reporting person filing this statement. It is a Louisiana charitable remainder unitrust, and its principal business address is PO Box 682838, Park City UT 84068-2838. Its principal business is to serve as a charitable trust and to facility estate planning. (d) None. (e) None. 5. SeaCap Management LLC is a reporting person filing this statement. It is a Wyoming limited liability company, and its principal business address is 9611 North US Hwy 1, Box 390, Sebastian FL 32958. Its principal business is to serve as a family investment manager. (d) None. (e) None. 6. (a) Linda Jenkins is a the trustee of the Linda Jenkins Charitable Remainder Unitrust, which is a reporting person filing this statement. (b) PO Box 682838, Park City UT 84068-283

Source and Amount of Funds or Other Consideration

Item 3. Source and Amount of Funds or Other Consideration See the Initial Schedule 13D for historical information. Item 4 below is incorporated by reference herein. The source of funds for all proposed purchases described in Item 4 below is cash on hand or working capital. The amount of funds used will depend on the trading price and volume of Company common stock and the amount of shares ultimately purchased. None of the funds used to make any purchases are or will be represented by funds or other consideration borrowed or otherwise obtained for the purpose of acquiring, holding, trading or voting Company common stock.

Purpose of Transaction

Item 4. Purpose of Transaction See the Initial Schedule 13D for historical information. On January 11, 2024, the Company announced that its Board of Directors has authorized Mr. David Jenkins and his affiliated companies to purchase up to 500,000 shares of Company common stock on the open market. Although it is Mr. Jenkins' current intent to engage in open market purchase transactions from time to time, his decision as to whether to engage in a purchase at any given time will depend upon a number of factors, including the current trading price of Company common stock and Mr. Jenkins' other capital needs. Mr. Jenkins also reserves the right to make purchases in private transactions. There is no guarantee that all or a substantial portion of the shares authorized as described above will in fact be purchased, and Mr. Jenkins reserves the right to make private purchases or purchases directly from the Company, subject to compliance with rules of the NYSE American. All purchases by Mr. Jenkins and affiliated companies will be made in compliance with all applicable laws, and all open market transactions will be conducted pursuant to Rule 10b-18 under the Securities Exchange Act of 1934, as amended. All acquisitions described above are expected to be for investment purposes. The reporting persons and other persons listed in Item 2 may make additional open market or other purchases or sales or engage in estate planning or other transactions in Company common stock, from time to time. Except as noted above and below in this Item 4, the reporting persons and the other persons listed in Item 2 have no present intent to take any action that would result in: (a) the acquisition by any person of additional securities of the Company or the disposition of securities of the Company; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Company or any subsidiary thereof; (c) a sale or transfer of a material amount of asset

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer See the Initial Schedule 13D for historical information. (a)-(b) See the cover pages to this Amendment. Ms. Linda Jenkins beneficially owns 2,264 shares of Company common stock as a result of her position as the sole trustee of the Linda Jenkins Charitable Remainder Trust. (c) There were no transactions in Company common stock effected by the reporting persons or the other persons listed in Item 2 within 60 days of the date hereof. See the Initial Schedule 13D for historical information. (d) None. (e) Not applicable.

Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer See the Initial Schedule 13D for historical information. Mr. Jenkins has agreed with the Company that all purchases described in Item 4 above will be made in compliance with all applicable laws, and that any such open market purchases will be made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

Material to be Filed as Exhibits

Item 7. Material to be Filed as Exhibits (A) Agreement of filing persons relating to filing of joint statement per Rule 13d-1(k). See the Initial Schedule 13D for historical information. CUSIP No. 74933X302 Page 12 of 13 Signature. After reasonable inquiry each of the undersigned certifies that to the best of his or her knowledge and belief the information set forth in this statement is true, complete and correct. /s/ David Jenkins Date: January 10, 2023 DAVID JENKINS FATBOY CAPITAL, L.P. By: SEACAP MANAGEMENT LLC, General Partner By: /s/ David Jenkins Date: January 10, 2023 David Jenkins, Managing Member SEACAP MANAGEMENT LLC By: /s/ David Jenkins Date: January 10, 2023 David Jenkins, Managing Member LINDA JENKINS CHARITABLE REMAINDER UNITRUST By: /s/ Linda Jenkins Date: January 10, 2023 Linda Jenkins, Trustee JENKINS FAMILY CHARITABLE INSTITUTE By: /s/ David Jenkins Date: January 10, 2023 David Jenkins, Trustee DALIN CLASS TRUST By: /s/ David Jenkins Date: January 10, 2023 David Jenkins, Trustee EXHIBIT A The undersigned each hereby certifies and agrees that the above Amendment to Schedule 13D concerning securities issued by Catheter Precision, Inc. is being filed on behalf of each of the undersigned. /s/ David Jenkins Date: January 10, 2023 DAVID JENKINS FATBOY CAPITAL, L.P. By: SEACAP MANAGEMENT LLC, General Partner By: /s/ David Jenkins Date: January 10, 2023 David Jenkins, Managing Member SEACAP MANAGEMENT LLC By: /s/ David Jenkins Date: January 10, 2023 David Jenkins, Managing Member LINDA JENKINS CHARITABLE REMAINDER UNITRUST By: /s/ Linda Jenkins Date: January 10, 2023 Linda Jenkins, Trustee JENKINS FAMILY CHARITABLE INSTITUTE By: /s/ David Jenkins Date: January 10, 2023 David Jenkins, Trustee DALIN CLASS TRUST By: /s/ David Jenkins Date: January 10, 2023 David Jenkins, Trustee

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.